RU99115705A - METHOD FOR TREATING INFLAMMATORY DISEASES AND DAMAGES OF THE ANTERIOR EYE SURFACE - Google Patents

METHOD FOR TREATING INFLAMMATORY DISEASES AND DAMAGES OF THE ANTERIOR EYE SURFACE

Info

Publication number
RU99115705A
RU99115705A RU99115705/14A RU99115705A RU99115705A RU 99115705 A RU99115705 A RU 99115705A RU 99115705/14 A RU99115705/14 A RU 99115705/14A RU 99115705 A RU99115705 A RU 99115705A RU 99115705 A RU99115705 A RU 99115705A
Authority
RU
Russia
Prior art keywords
inflammatory diseases
treating inflammatory
damages
anterior eye
eye surface
Prior art date
Application number
RU99115705/14A
Other languages
Russian (ru)
Other versions
RU2178684C2 (en
Inventor
Наталья Борисовна Чеснокова
Александр Валерьевич Пекшев
Татьяна Павловна Кузнецова
Original Assignee
Московский научно-исследовательский институт глазных болезней им. Гельмгольца
Filing date
Publication date
Application filed by Московский научно-исследовательский институт глазных болезней им. Гельмгольца filed Critical Московский научно-исследовательский институт глазных болезней им. Гельмгольца
Priority to RU99115705A priority Critical patent/RU2178684C2/en
Priority claimed from RU99115705A external-priority patent/RU2178684C2/en
Publication of RU99115705A publication Critical patent/RU99115705A/en
Application granted granted Critical
Publication of RU2178684C2 publication Critical patent/RU2178684C2/en

Links

Claims (4)

1. Способ лечения воспалительных заболеваний и повреждений переднего отрезка глаза, отличающийся тем, что осуществляют воздействие газовым потоком, содержащим оксид азота, при температуре 25-30oС па поверхности глаза.1. A method of treating inflammatory diseases and injuries of the anterior segment of the eye, characterized in that they effect the gas stream containing nitric oxide at a temperature of 25-30 o C on the surface of the eye. 2. Способ по п.1, отличающийся тем, что воздействие осуществляют в течение 1 мин 1 раз в сутки. 2. The method according to claim 1, characterized in that the effect is carried out for 1 min 1 time per day. 3. Способ по п. 1, отличающийся тем, что воздействие осуществляют до появления признаков начала эпителизации и рубцевания. 3. The method according to p. 1, characterized in that the effect is carried out until the onset of signs of epithelization and scarring. 4. Способ по п.1, отличающийся тем, что в плазменном потоке содержится 250-300 мг/м3 оксида азота.4. The method according to claim 1, characterized in that the plasma stream contains 250-300 mg / m 3 nitric oxide.
RU99115705A 1999-07-20 1999-07-20 Method for treating inflammatory diseases and injuries of anterior eye surface RU2178684C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99115705A RU2178684C2 (en) 1999-07-20 1999-07-20 Method for treating inflammatory diseases and injuries of anterior eye surface

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99115705A RU2178684C2 (en) 1999-07-20 1999-07-20 Method for treating inflammatory diseases and injuries of anterior eye surface

Publications (2)

Publication Number Publication Date
RU99115705A true RU99115705A (en) 2001-05-10
RU2178684C2 RU2178684C2 (en) 2002-01-27

Family

ID=20222873

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99115705A RU2178684C2 (en) 1999-07-20 1999-07-20 Method for treating inflammatory diseases and injuries of anterior eye surface

Country Status (1)

Country Link
RU (1) RU2178684C2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529058C2 (en) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasma generating device, plasma surgical device, use of a plasma surgical device and method for forming a plasma
SE529053C2 (en) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasma generating device, plasma surgical device and use of a plasma surgical device
SE529056C2 (en) 2005-07-08 2007-04-17 Plasma Surgical Invest Ltd Plasma generating device, plasma surgical device and use of a plasma surgical device
US7928338B2 (en) 2007-02-02 2011-04-19 Plasma Surgical Investments Ltd. Plasma spraying device and method
US7589473B2 (en) 2007-08-06 2009-09-15 Plasma Surgical Investments, Ltd. Pulsed plasma device and method for generating pulsed plasma
US8735766B2 (en) 2007-08-06 2014-05-27 Plasma Surgical Investments Limited Cathode assembly and method for pulsed plasma generation
US8613742B2 (en) 2010-01-29 2013-12-24 Plasma Surgical Investments Limited Methods of sealing vessels using plasma
US9089319B2 (en) 2010-07-22 2015-07-28 Plasma Surgical Investments Limited Volumetrically oscillating plasma flows
WO2022047227A2 (en) 2020-08-28 2022-03-03 Plasma Surgical Investments Limited Systems, methods, and devices for generating predominantly radially expanded plasma flow

Similar Documents

Publication Publication Date Title
PT1137430E (en) THERAPY FOR REMOVING NOISE FROM RESSONAR
CA2328368A1 (en) Anti-inflammatory agents
ECSP044992A (en) INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
PL330407A1 (en) Substituted cyclopentane compounds useful as neuraminidaze inhibitors
DE60036968D1 (en) Adamantane derivatives for the treatment of inflammatory, immunological and cardiovascular diseases
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
RU99115705A (en) METHOD FOR TREATING INFLAMMATORY DISEASES AND DAMAGES OF THE ANTERIOR EYE SURFACE
DE60205899D1 (en) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
NO991619L (en) Use of an H +, K + -ATPase inhibitor in the treatment of nasal polyps
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
IS2514B (en) Remediation of systemic and respiratory distress caused by viruses by suspending bioavailability of the beta-beta process
DE60026491D1 (en) MELAGATRAN FOR THE TREATMENT OF INFLAMMATION
DE69735417D1 (en) 2,5-DIHYDROXYBENZYLSULFON DERIVATIVES FOR THE TREATMENT OF SEXUAL DISORDERS
EA200200518A1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF PULMONARY DISEASES
MX22991A (en) SWEETENING AGENT DERIVED FROM L-ASPARTIC OR L-GLUTAMIC ACID AND THE PROCEDURE FOR ITS PREPARATION.
DE69737088D1 (en) THERAPEUTIC AGENT FOR THE TREATMENT OF FIV INFECTIONS
ITMI922657A1 (en) THERAPEUTIC COMPOSITION FOR RECTAL USE BASED ON FLUNISOLIDE AND / OR ITS FOREIGN TREATMENTS FOR INFLAMMATORY INTESTINAL DISORDERS
RU95102777A (en) Method of treatment of reperfuse myocardial damage and "deafening"
ATE308986T1 (en) USE OF 17-ALPHA-ESTRADIOL DERIVATIVES FOR THE THERAPY OF ADVERSE EFFECTS DURING AND/OR AFTER GNRHA THERAPY
RU99110352A (en) APPLICATION OF PERFUOROAN FOR TREATMENT OF CHEMICAL DAMAGES OF THE LUNGS AND METHOD OF ITS INTRODUCTION
RU2000118524A (en) METHOD FOR TREATING PATIENTS WITH RED FLAT
TR199800850T2 (en) Kan� d�zenleyici bile�imler.
RU2002106368A (en) METHOD FOR TREATING HERPETIC STOMATITIS
RU93027489A (en) METHOD OF SURGICAL CORRECTION OF CHRONIC DISORDERS OF DUODENAL PASSIBILITY